Loading…
Loading…
The VictoryShares US EQ Income Enhanced Volatility Wtd ETF aims to mirror the investment outcomes of the Nasdaq Victory US Large Cap High Dividend 100 Long/Cash Volatility Weighted Index (referred to as the "Long/Cash Index"), prior to the deduction of fees and expenses. This fund utilizes a distinctive "Volatility Weighting" approach, which integrates fundamental criteria with volatility-based weighting in an effort to achieve superior performance compared to conventional market-capitalization-weighted index strategies. A key characteristic of the Long/Cash Index is its adaptive mechanism…
Is CDC's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.
Baby formula maker Nara Organics said it is voluntarily recalling all of its infant formula, currently available in the United States, over potential risk of bacterial contamination.
Mattress Firm Heats Up Summer Savings with its Annual July 4th Sale PR Newswire HOUSTON, June 10, 2026
CLPS Incorporation Restructures R&D Architecture, Introduces AI Rainstorm Factory Development Model PR Newswire
WHO-flagged Ebola outbreak and rising hantavirus exposure risks underscore growing institutional demand for scalable, hospital-grade decontamination solutions across healthcare, hospitality, transportation, and agricultural infrastructure. WHO-flagged Ebola outbreak and rising hantavirus exposure risks underscore growing institutional demand for scalable, hospital-grade decontamination solutions across healthcare, hospitality, transportation, and agricultural infrastructure.
Tarrytown, NY, USA, May 04, 2026 (GLOBE NEWSWIRE) -- Siemens Healthineers announced its Atellica IM Testosterone II (TSTII) assay has achieved certification through the Centers for Disease Control and Prevention (CDC) Hormone Standardization Program for Total Testosterone (HoSt-TT). This certifies that the Atellica IM TSTII immunoassay's test results are equivalent to high performance liquid chromatography coupled with tandem mass spectrometry, which is regarded as the gold‑standard analytical approach [1,2]. The Atellica IM TSTII assay, available on the Atellica IM and Atellica CI Analyzers, is the only fully automated immunoassay to achieve CDC HoSt-TT certification, which it has maintained continuously since 2019 [3]. An evaluation of the assay's performance was recently published in The Journal of Clinical Endocrinology & Metabolism.